Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

A Cohort Study in Newly Diagnosed MZL

NCT06449885

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

NCT07233720

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China

View Trial Details

Recruiting

Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

NCT07188077

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma

NCT07198230

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations: The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

NCT06716658

Conditions: Cutaneous T Cell Lymphoma, Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +22 more
Locations: Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China

Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )

NCT07053670

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhang, Hubei, China

View Trial Details

Recruiting

PEEP-induced Effects on Respiratory dRivE and EFfort

NCT07203781

Conditions: ARDS (Moderate or Severe), Acute Hypoxemic Respiratory Failure, Hemic and Lymphatic Diseases, +12 more
Locations: Radboudumc Nijmegen, Gelderland, Netherlands

View Trial Details

Recruiting

Long-term Follow-up Study of Patients Receiving CAR-T Cells

NCT03375619

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +41 more
Locations: Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

NCT06420089

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Columbia University Irving Medical Center New York, United States

University of Pennsylvania - Abramson Caner Center Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions: B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Augusta Cancer Center Augusta, Georgia, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions